Immucell (ICCC) Q1 2024 Annual Earnings
ICCC·Reported May 14, 2024·After market close
Immucell reported Q1 2024 revenue of $7.3M, beat analyst consensus of $5.4M by $1.9M. Diluted EPS came in at $-0.06.
Revenue
$7.3Mbeat by $1.9M
Consensus: $5.4MDiluted EPS
$-0.06
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Immucell's Q1 2024 earnings report.
Immucell (ICCC) reported Q1 2024 earnings on May 14, 2024 after market close.
Immucell reported revenue of $7.3M and diluted EPS of $-0.06 for Q1 2024.
Revenue beat the consensus estimate of $5.4M by $1.9M.
You can read the 10-K periodic report (0001213900-24-028718) directly on SEC EDGAR. The filing index links above go to sec.gov.